Enhanced Multimodal Effect of Chemotherapy, Hyperthermia and Magneto-Mechanic Actuation of Silver-Coated Magnetite on Cancer Cells

Abstract

Currently, various methods based on magnetic nanoparticles are being considered for the treatment of cancer. Among these, magnetic hyperthermia and magneto-mechanical actuation are the most tested physical methods that have shown promising results when applied both separately and in combination. However, combining them with specific drugs can further improve antitumor efficiency. In this study, we performed a systematic analysis to determine the best combination of hyperthermia, magneto-mechanical actuation of silver-coated magnetite nanoparticles (MNP@Ag) and chemotherapy (mitoxantrone) capable of destroying tumor cells in vitro while maintaining normal cells in their state of increased viability. The results showed that of the nine treatment configurations, the only one that satisfied the safety condition for normal cells (fibroblasts) and the highly cytotoxic condition for tumor cells (HeLa) was the combination of all three triggers. This combination led to the decrease in HeLa viability to about 32%, while the decrease in fibroblast viability reached 80%. It was observed that the cytotoxic effect was not a sum of the separate effects of each trigger involved, but the result of a nonlinear conjugation of the triggers in a dynamic regime imposed by the magneto-mechanical actuation of the nanoparticles. We conclude that by using such a treatment approach, the need for chemotherapeutic drugs can be substantially reduced while maintaining their therapeutic performance.

Recent Advances in Micro- and Nano-Drug Delivery Systems Based on Natural and Synthetic Biomaterials

“…Nanomedicine is a subspecialty of medicine that makes use of nanoscale materials, such as biocompatible nanoparticles [6] and nanorobots [7], to carry out a variety of biological tasks, such as diagnostics [8], transportation [9], sensing [10], and actuation [11]. Before the conventional method of formulating vaccinations was established, medicines with very low aqueous solubility presented a number of difficulties in terms of biopharmaceutical delivery.…”